Biotech · Private company
Myovant Sciences GmbH
Track this companyFree. Adds Myovant Sciences GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials130 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- Estradiol/norethindrone acetatePhase 3 · Uterine LeiomyomaClinicalTrials.gov · fetched Nov 12, 2026
- Estradiol/norethindrone acetatePhase 3 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- Estradiol/norethindrone acetatePhase 3 · Endometriosis Related PainClinicalTrials.gov · fetched Nov 12, 2026
- Estradiol/norethindrone acetatePhase 3 · Heavy Menstrual BleedingClinicalTrials.gov · fetched Nov 12, 2026
- Leuprolide AcetatePhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- RelugolixPhase 3 · Endometriosis Related PainClinicalTrials.gov · fetched Nov 12, 2026
- RelugolixPhase 3 · Uterine LeiomyomaClinicalTrials.gov · fetched Nov 12, 2026
- RelugolixPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- RelugolixPhase 3 · EndometriosisClinicalTrials.gov · fetched Nov 12, 2026
- RelugolixPhase 3 · Heavy Menstrual BleedingClinicalTrials.gov · fetched Nov 12, 2026
- E2/NETAPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- ErythromycinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- RelugolixPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Relugolix/E2/NETA FDCPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)PHASE4 · WITHDRAWN · started Nov 20, 2022ClinicalTrials.gov NCT05538689 · fetched Nov 12, 2026
- Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation TherapyNA · COMPLETED · started Mar 8, 2022ClinicalTrials.gov NCT05324098 · fetched Nov 12, 2026
- A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult MenPHASE1 · COMPLETED · started Jan 6, 2021ClinicalTrials.gov NCT04714554 · fetched Nov 12, 2026
- Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsPHASE3 · COMPLETED · started Oct 16, 2018ClinicalTrials.gov NCT03751124 · fetched Nov 12, 2026
- Bone Mineral Density in Women With Uterine Fibroids or EndometriosisCOMPLETED · started Aug 3, 2018ClinicalTrials.gov NCT03744507 · fetched Nov 12, 2026
- SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated PainPHASE3 · COMPLETED · started May 22, 2018ClinicalTrials.gov NCT03654274 · fetched Nov 12, 2026
- SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated PainPHASE3 · COMPLETED · started Dec 7, 2017ClinicalTrials.gov NCT03204318 · fetched Nov 12, 2026
- SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated PainPHASE3 · COMPLETED · started Nov 1, 2017ClinicalTrials.gov NCT03204331 · fetched Nov 12, 2026
- LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsPHASE3 · COMPLETED · started Oct 19, 2017ClinicalTrials.gov NCT03412890 · fetched Nov 12, 2026
- LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsPHASE3 · COMPLETED · started Jun 14, 2017ClinicalTrials.gov NCT03103087 · fetched Nov 12, 2026
- LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsPHASE3 · COMPLETED · started Apr 26, 2017ClinicalTrials.gov NCT03049735 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate CancerPHASE3 · COMPLETED · started Apr 18, 2017ClinicalTrials.gov NCT03085095 · fetched Nov 12, 2026
- Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female ParticipantsPHASE1 · COMPLETED · started Jun 16, 2016ClinicalTrials.gov NCT04978688 · fetched Nov 12, 2026